Oura Buys Counsel Health for $625 Million: The Wearable That Wants to Be a Doctor

Six weeks after pulling its IPO, the smart ring maker is spending $625 million in cash on an AI-native primary care company that raised $36 million. The price says less about Counsel’s revenue than about what Oura needs public investors to believe: that it is a health platform, not a hardware company.

The short answer: Oura announced on November 10, 2026 that it will acquire Counsel Health, an AI-enabled, physician-supervised virtual primary care company, for $625 million in cash. Counsel had disclosed $36 million in venture funding, led by Andreessen Horowitz and GV. The two companies have run an in-app partnership since May 2026 and a joint Medicare chronic care program is set to start in early 2027. Closing timing and conditions were not disclosed in the reports we reviewed. The deal has not closed.

$625Mpurchase price, all cash
$36Mdisclosed venture funding into Counsel
~17xprice over capital raised
5.7MOura paid members as of late September 2026
  • This is a partnership turned acquisition. Oura tested Counsel inside its app for about six months before buying it, and 36,000 members onboarded in the first nine weeks.
  • Oura is buying a care license, not just software. Counsel brings licensed physicians in 43 states, enterprise contracts with plans and employers, and a seat in Medicare’s ACCESS model.
  • The timing points at the IPO. Oura postponed its Nasdaq listing on September 29 amid investor pushback on valuation and a revenue mix that is about 80 percent hardware.
  • No real estate changes hands. Counsel is fully virtual. The property question is second order: what AI front doors do to low-acuity visit volume over time.

Deal Facts

BuyerOura Inc., San Francisco (Delaware parent of Oura Health Oy since March 31, 2026)
TargetCounsel Health, AI-native virtual primary care, New York
Price$625 millionReported
ConsiderationCashReported
AnnouncedNovember 10, 2026
StatusAnnounced, not closed
Counsel founder and CEOMuthu Alagappan, MD
Counsel founded2023
Counsel investorsAndreessen Horowitz, GV, Asymmetric Capital Partners, Floodgate, Pear VC
Advisors and closing termsNot disclosed in reports reviewed

“Reported” means the figure comes from news coverage of the announcement, including STAT News and a Reuters brief, not from a filing we have read.

What the Price Actually Buys

Counsel’s revenue has not been disclosed, so the $625 million cannot be read as a revenue multiple. What it can be read against is what it buys.

A proven conversion path

Inside the Oura app since June 16, 2026

Oura’s chief medical officer said 36,000 members completed Counsel onboarding in nine weeks, with 70 percent satisfied. Members who saw a physician rated care 4.6 out of 5. The in-app tier is now $159 a year after a 30-day free trial.

A licensed care network

43 states

Counsel’s physicians diagnose, prescribe and refer. The eight jurisdictions it does not cover require a video visit to establish care, which Counsel does not yet offer.

Enterprise channels

Plans, employers, white label

More than 100,000 members through health plan and employer partners by October 2025, a Businessolver benefits marketplace listing in March 2026, and Counsel Studio, a white-label platform launched July 2026.

A Medicare wedge

CMS ACCESS model, early 2027

Counsel joined the early cardio-kidney-metabolic track of CMS’s 10-year ACCESS model, with Oura as preferred wearable partner. That is a payer-funded revenue line, not a consumer subscription.

Why Oura Wants It

Oura’s growth is real. Revenue reached $1.21 billion in the nine months to June 30, 2026, up 74 percent, with net income of $60.8 million. Membership revenue grew 121 percent to $240.5 million. But hardware still made up about 80 percent of revenue, and that is where the IPO stalled. Oura postponed its offering on September 29, citing market uncertainty, after marketing 50 million shares at $40 to $44. Fortune reported that analysts suspected valuation concerns and an insider cash-out; about 36.5 million of the 50 million shares were being sold by existing holders.

Owning Counsel answers the bear case directly. Oura’s own prospectus described a goal of serving members across “tracking, sensing, diagnosing, treatment, and continuous monitoring.” A physician network turns the last three from partner promises into owned capability, and every Counsel subscription is recurring revenue at software-like scale. This is also not Oura’s first acquisition: it bought Proxy in 2023, and Veri and Sparta Science in 2024. Counsel is by far the largest.

The Real Estate

There is no real estate in this deal. Counsel is a messaging-first virtual practice with no clinic footprint. The relevance to medical property owners is indirect and, for now, a hypothesis rather than a measured effect.

Counsel sells itself to health plans on reducing unnecessary emergency department use and downstream utilization, and as a replacement for nurse triage lines and conventional telehealth. If AI front doors at Oura’s scale shift low-acuity visits away from urgent care and primary care sites, that would show up first in visit counts at those locations, long before it shows up in lease renewals. Our read: watch it, do not price it in. Specialty, procedural and diagnostic space is the least exposed, because a chatbot cannot do a scan or a procedure.

HREF

Refinancing or buying medical real estate while care delivery shifts? Healthcare Real Estate Fund arranges debt for maturing medical property loans and acquisition financing for healthcare real estate.

Talk to Healthcare Real Estate Fund

The Operating Business

Counsel’s model is AI first and physician supervised. A medical-grade AI collects history and gives initial guidance, then escalates to in-house physicians for diagnosis, prescriptions and referrals. It integrates with national health information exchanges to pull records. In April 2026 it began treating lifestyle conditions such as hair loss, acne and sexual health for $29 a consultation, with chronic conditions including hypertension, high cholesterol and obesity to follow. The company says the platform saves an average of $381 a year per engaged member, a company claim we have not seen independently verified.

Market Context

The deal sits at the meeting point of two trends. The first is consumer wearables moving into clinical care: Oura already works with Dexcom on glucose, LillyDirect, and Resmed on sleep, and Apple, Google and Samsung can bundle health features with phones and operating systems. The second is AI-native care delivery attracting strategic buyers in a thin venture market. CB Insights reported the fewest digital health deals in over a decade in Q2 2026, even as median deal sizes rose. The closest large precedent for a consumer company buying primary care is Amazon’s $3.9 billion acquisition of One Medical, which closed in February 2023. That bought clinics; this buys an AI layer and a license to practice.

Timeline

  • Summer 2023Muthu Alagappan and Rishi Kerkar found Counsel Health.
  • October 2024$11 million seed led by Andreessen Horowitz Bio + Health.
  • October 2025$25 million Series A led by Andreessen Horowitz and GV; consumer AI access opens. Oura raises more than $900 million at about an $11 billion valuation.
  • March 2026Counsel joins Businessolver’s Pinnacle Partners benefits program.
  • April 2026Counsel expands into lifestyle and chronic condition care.
  • May 28, 2026Oura and Counsel announce their in-app partnership; rollout begins June 16 in 43 states.
  • July 28, 2026Counsel launches Counsel Studio, a white-label care platform.
  • September 17, 2026Counsel joins the CMS ACCESS model with Oura as preferred wearable partner.
  • September 29, 2026Oura postpones its Nasdaq IPO and reports 5.7 million paid members.
  • October 13, 2026Counsel’s paid tier begins in the Oura app at $159 a year.
  • November 10, 2026Oura announces the $625 million cash acquisition of Counsel.
  • Early 2027Counsel’s ACCESS Medicare chronic care program is scheduled to begin.

What It Means

For venture investors: AI-native care companies have a strategic exit path that does not run through an IPO. Counsel went from a seed round to a $625 million cash sale in about two years, and the buyer was a partner that had already measured the product inside its own app.

For founders: distribution partnerships with consumer platforms are acquisition auditions. The data from the partnership is the diligence.

For Oura: the acquisition strengthens the platform story it needs when it returns to the IPO market, but it also adds clinical liability, state licensing and HIPAA obligations to a consumer hardware company.

HD

What members actually get. Healthcare Discovery breaks down the Counsel service inside the Oura app: what it costs, where it works, what data it sees and when to use it.

Read the member guide on Healthcare Discovery

What to Watch Next

  1. Closing and terms. Timing, conditions and whether Counsel’s leadership stays.
  2. Enterprise customer retention. Health plans and employers that bought Counsel as a neutral front door may think twice now that a device company owns it.
  3. Pricing inside Oura. Whether Counsel stays a $159 add-on or folds into Oura membership.
  4. Privacy terms. How consumer ring data and HIPAA-covered medical records are governed under one parent.
  5. Coverage. Whether video visits arrive and close the eight-jurisdiction gap.
  6. ACCESS results. Enrollment and outcomes once the Medicare program starts in 2027.
  7. The IPO. Whether Oura refiles and how much of the pitch rests on care services.

Questions People Ask

How much is Oura paying for Counsel Health?

$625 million in cash, according to the announcement as reported by STAT News and Reuters.

Who invested in Counsel Health?

Andreessen Horowitz led the $11 million seed with Asymmetric Capital Partners, Floodgate and Pear VC participating. Andreessen Horowitz and GV led the $25 million Series A.

Is Oura a public company?

No. Oura filed to list on Nasdaq under the ticker OURA but postponed the IPO on September 29, 2026.

Will Counsel stay available outside the Oura app?

Not disclosed. Counsel currently serves consumers directly, through health plans and employers, and through white-label partners.

Related Deals

How We Built This Page

Built from the November 10, 2026 announcement coverage, Oura’s IPO filings and postponement statement, Counsel Health press releases, Oura support documentation and trade press. Deal terms beyond price and consideration were not public at the time of writing. Figures marked as company claims have not been independently verified. Healthcare Venture Capital Fund is an editorial platform and has no position in Oura or Counsel Health.

Sources

  • STAT News, “Oura to acquire Counsel Health for $625 million, placing a big bet on AI care,” November 10, 2026.
  • Reuters brief, “Oura says to acquire Counsel Health for $625 million in cash,” November 10, 2026.
  • Oura Inc., Form S-1 and S-1/A, SEC, September 2026.
  • IPO Scoop, “Oura postpones IPO due to market conditions,” September 29, 2026; Fortune, “Why Oura really pulled its IPO,” October 6, 2026.
  • Saxo, “Oura IPO: Can a smart ring become a health platform?” September 29, 2026.
  • Fierce Healthcare, “Oura, Counsel Health join CMS ACCESS model,” September 17, 2026.
  • Business Wire, Counsel Health releases of April 7, July 28 and September 17, 2026; Businessolver release, March 25, 2026.
  • Oura Support, “Oura Labs: Counsel Health,” October 2026.
  • Fierce Healthcare, “Counsel Health raises $25M series A,” October 2025; Healthcare IT Today, Counsel seed announcement, October 2024.
  • HIT Consultant, CB Insights Q2 2026 State of Digital Health report summary.